透景在医疗器械行业中的票数：84
【透景是哪个国家的品牌？】
成立于2003年，立足于自主创新、构建了多个技术平台，肿瘤标志物和HPV检测领域中检测项目齐全、技术靠前的公司
上海透景生命科技股份有限公司(简称“透景生命”)成立于2003年，公司位于有“中国药谷”之称的上海张江高科技园区。
透景生命于2017年4月12日成功上市，股票代码：300642。
透景生命立足于自主创新，构建了高通量流式荧光杂交技术平台、高通量流式免疫荧光技术平台、多重荧光PCR技术平台、化学发光免疫分析技术平台等多个技术平台。各平台互为补充，各有所长：高通量流式荧光技术平台具有一次检测多种指标、并行检测通量高、检测速度快等显著特点，可以广泛应用于多指标联检产品的开发；化学发光技术平台具有灵敏度高、特异性强、线性范围宽、自动化程度高等优势，适用于单指标免疫诊断产品的开发；多重荧光PCR平台主要用于分子产品的开发；同时透景在2018年隆重推出 日立-透景兼容性流水线 ，实现实验室全自动化。
透景生命在肿瘤检测、宫颈癌筛查、DNA甲基化检测、男性不育和优生优育等多个领域推出了众多系列化创新性产品，已成为国内乃至国际上肿瘤标志物和HPV检测领域中检测项目齐全、技术靠前的公司。透景科技已累计获得50余项医疗器械注册证书，产品涉及肿瘤标志物、宫颈癌筛查、肺癌DNA甲基化、男性不育、基因突变检测、优生优育、肿瘤质控品等。
英文翻译：Founded in 2003, based on independent innovation and construction of multiple technical platforms, Shanghai toujing Life Technology Co., Ltd. (hereinafter referred to as "toujing life"), a company with complete testing projects and advanced technology in the field of tumor markers and HPV detection, was founded in 2003. The company is located in Shanghai Zhangjiang high tech park, known as "China Pharmaceutical Valley". Toujing life was successfully listed on April 12, 2017, stock code: 300642. Based on independent innovation, transview life has built a number of technical platforms, including high-throughput flow-through fluorescent hybridization technology platform, high-throughput flow-through immunofluorescence technology platform, multiple fluorescent PCR technology platform, chemiluminescence immunoassay technology platform, etc. Each platform complements each other and has its own advantages: the high-throughput flow cytometry platform has the remarkable characteristics of one-time detection of multiple indicators, high parallel detection flux and fast detection speed, which can be widely used in the development of multi indicator joint inspection products; the chemiluminescent technology platform has the advantages of high sensitivity, strong specificity, wide linear range and high degree of automation, which is suitable for single indicator immunization The development of diagnostic products; the multi fluorescence PCR platform is mainly used for the development of molecular products; at the same time, transparency grandly launched the Hitachi transparency compatibility pipeline in 2018, realizing full automation of the laboratory. Transparence life has launched many series of innovative products in tumor detection, cervical cancer screening, DNA methylation detection, male infertility, eugenics and other fields, and has become a company with complete detection projects and advanced technology in the field of tumor markers and HPV detection at home and abroad. Transview technology has obtained more than 50 medical device registration certificates, including tumor markers, cervical cancer screening, DNA methylation of lung cancer, male infertility, gene mutation detection, eugenics, tumor quality control products, etc.
本文链接： https://www.waitui.com/brand/538bc21d1.html 联系电话：400-035-8689,400-035-8689
浙公网安备 33011802001999号
